Quaternary Prevention, an Answer of Family Doctors to Overmedicalization

Publish Year: 1394
نوع سند: مقاله ژورنالی
زبان: English
View: 7

متن کامل این Paper منتشر نشده است و فقط به صورت چکیده یا چکیده مبسوط در پایگاه موجود می باشد.
توضیح: معمولا کلیه مقالاتی که کمتر از ۵ صفحه باشند در پایگاه سیویلیکا اصل Paper (فول تکست) محسوب نمی شوند و فقط کاربران عضو بدون کسر اعتبار می توانند فایل آنها را دریافت نمایند.

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_HPM-4-2_002

تاریخ نمایه سازی: 16 مرداد 1403

Abstract:

In response to the questioning of Health Policy and Management (HPAM) by colleagues on the role of rank and file family physicians in the same journal, the author, a family physician in Belgium, is trying to highlight the complexity and depth of the work of his colleagues and their contribution to the understanding of the organization and economy of healthcare. It addresses, in particular, the management of health elements throughout the ongoing relationship of the family doctor with his/her patients. It shows how the three dimensions of prevention, clearly included in the daily work, are complemented with the fourth dimension, quaternary prevention or prevention of medicine itself, whose understanding could help to control the economic and human costs of healthcare.

Authors

Marc Jamoulle

Espace Temps, Maison de Santé, Charleroi, Belgium, and Department of General Practice, University of Liege, Liège, Belgium

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • Chinitz DP, Rodwin VG. On Health Policy and Management (HPAM): ...
  • Harrison C, Britt H, Miller G, Henderson J. Prevalence of ...
  • Gijsen R, Poos R. Using registries in general practice to ...
  • Lykkegaard J, Larsen PV, Paulsen MS, Søndergaard J. General practitioners’ ...
  • Laux G, Kuehlein T, Rosemann T, Szecsenyi J. Co- and ...
  • Lamberts H, Meads S, Wood M. Classification of reasons why ...
  • Soler JK, Okkes I, Wood M, Lamberts H. The coming ...
  • Leavell H, Clark E. Preventive Medicine for the Doctor in ...
  • Jamoulle M. Information et informatisation en médecine générale [Computer and ...
  • Jamoulle M, Roland M. Quaternary prevention. WICC annual workshop: Hongkong, ...
  • Jamoulle M. The four duties of family doctors: quaternary prevention ...
  • Bentzen N. Wonca Dictionary of General/Family Practice. Maanedsskr: Copenhagen; ۲۰۰۳ ...
  • Norman AH, Tesser CD. [Quaternary prevention in primary care: a ...
  • De Vito EL. Prevención cuaternaria, un término aún no incluido ...
  • Silva AL, Mangin D, Pizzanelli M, Jamoulle M, Wagner HL, ...
  • Kuehlein T, Sghedoni D, Visentin G, Gérvas J, Jamoulle M. ...
  • Jamoulle M, Tsoi G, Heath I, Mangin D, Pezeshki M, ...
  • Martin C, Heleno B, Hestbech M, Brodersen J. Screening Evidence ...
  • Jamoulle M, Roland M. Quaternary prevention. From Wonca world Hong ...
  • Tsoi G. Quaternary prevention. Hong Kong Pract ۲۰۱۴; ۳۶: ۴۹-۵۰ ...
  • Alonso-Coello P, García-Franco AL, Guyatt G, Moynihan R. Drugs for ...
  • Conrad P, Bergey MR. The impending globalization of ADHD: Notes ...
  • Moynihan R, Heath I, Henry D. Selling sickness: the pharmaceutical ...
  • Gøtzsche PC, Nielsen M. Screening for breast cancer with mammography. ...
  • Tomljenovic L, Shaw CA. Human papillomavirus (HPV) vaccine policy and ...
  • Wolinsky H. Disease mongering and drug marketing. Does the pharmaceutical ...
  • Mariño Maria A. Incidentaloma. Rev Bras Med Família e Comunidade ...
  • Welch HG. Overdiagnosed: Making People Sick in the Pursuit of ...
  • Heath I. Combating Disease Mongering: Daunting but Nonetheless Essential. PLoS ...
  • Kuehlein T, Sghedoni D, Visentin G, Gérvas J, Jamoulle M. ...
  • Light DW, Lexchin J, Darrow JJ. Institutional Corruption of Pharmaceuticals ...
  • Rodwin MA. Institutional Corruption & Pharmaceutical Policy. J Law Med ...
  • Gotzsche PG. Deadly Medicines and Organised Crime: How Big Pharma ...
  • Mangin D, Heath I, Jamoulle M. Beyond diagnosis: rising to ...
  • Giguere A, Labrecque M, Haynes R, Grad R, Pluye P, ...
  • Feldman AM. Understanding Health Care Reform: Bridging the Gap Between ...
  • Lancaster T, Stead L, Silagy C, Sowden A. Effectiveness of ...
  • Welch HG, Passow HJ. Quantifying the benefits and harms of ...
  • Lipska KJ, Ross JS, Miao Y, Shah ND, Lee SJ, ...
  • Al-Nabhani K, Kakaria A, Syed R. Computed tomography in management ...
  • Légaré F, Ratté S, Stacey D, Kryworuchko J, Gravel K, ...
  • Widmer D, Herzig L, Jamoulle M. [Quaternary prevention: is acting ...
  • Heath I. The art of doing nothing. Eur J Gen ...
  • Báez EM. Princípios Éticos e Prevenção Quaternária: é possível não ...
  • Sharpe VA. Why “Do No Harm”? The Influence of Edmund ...
  • نمایش کامل مراجع